Cost-Benefit Analyses for Alcohol Dependence Treatment
Author Information
Author(s): Svetlana Popova, Satya Mohapatra, Jayadeep Patra, Amy Duhig, Jürgen Rehm
Primary Institution: Centre for Addiction and Mental Health
Hypothesis
The study aims to evaluate the economic impact of pharmacotherapy and psychotherapy treatments for alcohol dependence through cost-benefit analyses.
Conclusion
Most treatment options for alcohol dependence yield significant economic benefits, with benefit-cost ratios ranging from 1.89 to 39.00.
Supporting Evidence
- Psychotherapy treatments showed significant cost savings within the first six months.
- Benefit-cost ratios for brief interventions ranged from 3.2 to 39.0.
- Acamprosate treatment resulted in net savings of 528 € per patient over 24 months.
Takeaway
This study looks at how much money can be saved by treating people with alcohol problems, showing that many treatments save more money than they cost.
Methodology
A literature search was conducted across multiple databases to identify studies on cost-benefit analyses of alcohol dependence treatments, followed by data extraction from selected articles.
Potential Biases
Potential biases may arise from the limited number of studies and the reliance on existing literature, which may not comprehensively cover all treatment options.
Limitations
The study is limited by the small number of cost-benefit analyses available for pharmacotherapy treatments and the variability in how benefits were calculated across studies.
Participant Demographics
The studies included various populations, including newly abstinent alcoholics, couples, and older adults, with sample sizes ranging from 36 to over 600,000.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website